Chronic L-dopa treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance

Brain Res. 1991 Dec 24;568(1-2):205-14. doi: 10.1016/0006-8993(91)91399-l.

Abstract

Two separate experiments were conducted to assess the behavioral and biochemical effects of chronic L-dihydroxyphenylalanine (L-DOPA) treatment in rats with unilateral 6-hydroxydopamine (6-OHDA) lesions. In this animal model, contralateral rotation provides the behavioral indicator response for L-DOPA activation of the dopamine denervated striatum. Following 30 daily L-DOPA treatments, a subthreshold dose (10 mg/kg) for rotation became suprathreshold and the contralateral rotation induced by a suprathreshold dose (20 mg/kg) became exaggerated. This motoric sensitization to L-DOPA was not reversed by a three-day period of L-DOPA withdrawal. In contrast with the emergence of behavioral sensitization to L-DOPA, biochemical measurements showed that the increase of dopamine metabolite concentrations (DOPAC and HVA) induced by acute L-DOPA treatment became attenuated with chronic treatment. This finding suggests that chronic L-DOPA treatment produces a partial tolerance in the conversion of L-DOPA to extracellular dopamine. The emergence of L-DOPA sensitization-over-stimulation effects was hypothesized to reflect the combined effects of dopamine receptor priming and Pavlovian drug conditioning and to contribute to the emergence of dyskinetic effects of L-DOPA therapy. The partial tolerance observed for dopamine metabolites was hypothesized to represent a decreased conversion of L-DOPA to dopamine which with long-term treatment could progress to an eventual wearing-off effect of L-DOPA therapy.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • 3,4-Dihydroxyphenylacetic Acid / metabolism
  • Animals
  • Apomorphine / pharmacology
  • Carbidopa / pharmacology
  • Corpus Striatum / physiology*
  • Denervation
  • Drug Tolerance
  • Functional Laterality
  • Homovanillic Acid / metabolism
  • Levodopa / analogs & derivatives
  • Levodopa / metabolism
  • Levodopa / pharmacology*
  • Male
  • Motor Activity / drug effects*
  • Oxidopamine / toxicity*
  • Rats
  • Rats, Inbred Strains
  • Substance Withdrawal Syndrome / physiopathology

Substances

  • 3,4-Dihydroxyphenylacetic Acid
  • Levodopa
  • Oxidopamine
  • levodopa methyl ester
  • Carbidopa
  • Apomorphine
  • Homovanillic Acid